| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2012 | US8263647 Treatment of sleep disturbances |
| 09/11/2012 | US8263646 Methods for the treatment of kidney disease |
| 09/11/2012 | US8263645 Disodium cromoglycate compositions and methods for administering same |
| 09/11/2012 | US8263644 Cytotoxic xanthone compounds |
| 09/11/2012 | US8263643 Polyphenol compounds with modulating neurotransmitter release |
| 09/11/2012 | US8263641 Compounds that modulate intracellular calcium |
| 09/11/2012 | US8263640 Inhibitors of fatty acid uptake and methods of use |
| 09/11/2012 | US8263639 Multifunctional metal-chelating ligands |
| 09/11/2012 | US8263638 Dosing regimens for ion channel modulating compounds |
| 09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
| 09/11/2012 | US8263636 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases |
| 09/11/2012 | US8263635 Inhibitors of CYP 17 |
| 09/11/2012 | US8263634 Heteroaryl-ureas and their use as glucokinase activators |
| 09/11/2012 | US8263633 Benzoxepin PI3K inhibitor compounds and methods of use |
| 09/11/2012 | US8263632 Aminopyridine derivatives having Aurora A selective inhibitory action |
| 09/11/2012 | US8263631 Anti-cancer pharmaceutical compositions and methods for treating patients with cancer |
| 09/11/2012 | US8263630 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 09/11/2012 | US8263629 Substituted aminobutyric derivatives as neprilysin inhibitors |
| 09/11/2012 | US8263628 Fluorine-containing organosulfur compound and pesticidal composition thereof |
| 09/11/2012 | US8263627 Pyridyl amide T-type calcium channel antagonists |
| 09/11/2012 | US8263624 Aryl-substituted heterocycles, and use thereof |
| 09/11/2012 | US8263623 Triazol derivatives useful for the treatment of diseases |
| 09/11/2012 | US8263622 Fused-ring derivative and medical application of same |
| 09/11/2012 | US8263621 Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 09/11/2012 | US8263620 Oxadiazole derivatives active on sphingosine-1-phosphate (SIP) |
| 09/11/2012 | US8263619 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 09/11/2012 | US8263618 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists |
| 09/11/2012 | US8263617 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/11/2012 | US8263616 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds |
| 09/11/2012 | US8263615 Bis-heterocyclic imidazolyl compounds |
| 09/11/2012 | US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 09/11/2012 | US8263613 Salts, prodrugs and polymorphs of fab I inhibitors |
| 09/11/2012 | US8263612 Propylaxic or therapy of viral infections; using pyrrolo( 2,3-c)pyridine |
| 09/11/2012 | US8263611 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative |
| 09/11/2012 | US8263610 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds |
| 09/11/2012 | US8263609 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands |
| 09/11/2012 | US8263608 Melanocortin receptor-specific spiro-piperidine compounds |
| 09/11/2012 | US8263607 1-substituted tetrahydroisoquinoline compound |
| 09/11/2012 | US8263606 Spiro-oxindole compounds and their use as therapeutic agents |
| 09/11/2012 | US8263605 Modulators of muscarinic receptors |
| 09/11/2012 | US8263604 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 09/11/2012 | US8263603 N3-substituted-N1-sulfonyl-5-fluoropyrimidinone derivatives |
| 09/11/2012 | US8263602 Matrix metalloproteinase inhibitors |
| 09/11/2012 | US8263601 Deuterium substituted xanthine derivatives |
| 09/11/2012 | US8263600 Antifungal composition with enhanced bioavailability |
| 09/11/2012 | US8263599 STAT3/5 activation inhibitor |
| 09/11/2012 | US8263598 Substituted sulfonamide compounds |
| 09/11/2012 | US8263597 Indazole compounds as CCR1 receptor antagonists |
| 09/11/2012 | US8263596 Kinase inhibitors and method of treating cancer |
| 09/11/2012 | US8263595 Triazolopyridine compounds and their use as ask inhibitors |
| 09/11/2012 | US8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 09/11/2012 | US8263593 Therapeutic compounds |
| 09/11/2012 | US8263592 Equilibrative nucleoside transporter ENT1 inhibitors |
| 09/11/2012 | US8263591 Bicyclic amides for enhancing glutamatergic synaptic responses |
| 09/11/2012 | US8263590 Pyrimidine derivatives |
| 09/11/2012 | US8263589 Inhibitors of protein aggregation |
| 09/11/2012 | US8263588 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/11/2012 | US8263587 Benzoxazepine compounds, their preparation and use |
| 09/11/2012 | US8263586 OXO bridged diazepan orexin receptor antagonists |
| 09/11/2012 | US8263585 Organic compounds |
| 09/11/2012 | US8263584 Imidazopyridines |
| 09/11/2012 | US8263583 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
| 09/11/2012 | US8263582 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects |
| 09/11/2012 | US8263581 Non-sedating antihistamine injection formulations and methods of use thereof |
| 09/11/2012 | US8263580 Vitamin formulation |
| 09/11/2012 | US8263579 Anti-inflammatory compounds |
| 09/11/2012 | US8263578 Stable bortezomib formulations |
| 09/11/2012 | US8263577 Water-soluble iron carbohydrate derivative complexes, the preparation thereof, and medicaments comprising them |
| 09/11/2012 | US8263576 Non-natural sphingolipid analogs and uses thereof |
| 09/11/2012 | US8263575 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/11/2012 | US8263574 Topical formulations for the treatment of depression with S adenosyl methionine |
| 09/11/2012 | US8263572 RNAi modulation of RSV and therapeutic uses thereof |
| 09/11/2012 | US8263571 Gene silencing of the brother of the regulator of imprinted sites (BORIS) |
| 09/11/2012 | US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin |
| 09/11/2012 | US8263566 Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″-or 4′-position |
| 09/11/2012 | US8263565 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same |
| 09/11/2012 | US8263564 Iron-carbohydrate complex compounds |
| 09/11/2012 | US8263559 Feline granulocyte macrophage colony stimulating factor proteins |
| 09/11/2012 | US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof |
| 09/11/2012 | US8263369 Compound ceramidastin, method for producing the same, and use of the same |
| 09/11/2012 | US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 09/11/2012 | US8263326 Compounds and methods for modulating activation of NF-κB |
| 09/11/2012 | US8263142 From olives; incubating the acidified water until at least 75 percent of oleoeuropein has been converted to hydroxytyrosol; nutraceuticals in tablet, capsule, pill or confection form; antioxidants |
| 09/11/2012 | US8263136 Low dose colonic cleansing system |
| 09/11/2012 | US8263131 Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug |
| 09/11/2012 | US8263128 Solid pharmaceutical dispersions with enhanced bioavailability |
| 09/11/2012 | US8263125 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients |
| 09/11/2012 | US8263124 Anthistamine-decongestant pharmaceutical compositions |
| 09/11/2012 | US8263123 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 09/11/2012 | US8263121 Solid pharmaceutical preparation |
| 09/11/2012 | US8263120 Oral antimicrobial pharmaceutical compositions |
| 09/11/2012 | US8263119 Capsule formulations containing lanthanum compounds |
| 09/11/2012 | US8263112 In vivo use of water absorbent polymers |
| 09/11/2012 | US8263111 Non-hormonal vaginal contraceptive |
| 09/11/2012 | US8263110 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix |
| 09/11/2012 | US8263108 Biodegradable insert; drug delivery |
| 09/11/2012 | US8263104 Polymer nanofilm coatings |
| 09/11/2012 | US8263098 High alcohol content foaming compositions with silicone-based surfactants |
| 09/11/2012 | US8263097 Methods and compositions for treating acne |
| 09/11/2012 | US8263093 Methods and compositions for administration of TRPV1 agonists |